• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

ICAHN


<







he's been back in the picture for a while now. Sorry you are just now hearing about it.
I was aware if his big buy in July, he's now upping the stakes. Sorry you didn't take the time to read the article, but that doesn't surprise me. Clearly the more he buys, the less stable for us (think Gordon Gecko).
 




I was aware if his big buy in July, he's now upping the stakes. Sorry you didn't take the time to read the article, but that doesn't surprise me. Clearly the more he buys, the less stable for us (think Gordon Gecko).
learn to read the article yourself--SEC disclosure is for July. Just revealing how MUCH not a new stake.
 




















Similar threads